Find clinical trials for Lymphoma in Toronto, ON
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Lymphoma trials near Toronto, ON, CAN:
The purpose of this study is to evaluate the safety, tolerability, and preliminary efficacy of CC-99282 alone and in combination with anti-lymphoma...
Phase 1, Phase 2
Toronto, Ontario, Canada and 88 other locations
Part 1: To characterize the safety profile of acalabrutinib alone or in combination with rituximab in subjects with R/R FL.Part 2: To characterize th...
Phase 1, Phase 2
Toronto, Ontario, Canada and 31 other locations
TrAVeRse is a multicentre, open-label, randomised, Phase II study of AVR in treatment naïve MCL participants. The primary objective will be to assess...
Phase 2
Toronto, Ontario, Canada and 47 other locations
This study will characterize the safety and clinical benefit of valemetostat tosylate in participants with relapsed/refractory peripheral T-cell lymphoma...
Phase 2
Toronto, Canada and 59 other locations
A Phase 2 study to evaluate the efficacy of nanatinostat in combination with valganciclovir in patients with relapsed/refractory EBV-positive lymphomas...
Phase 2
Toronto, Ontario, Canada and 93 other locations
The purpose of this study is to find out if lenalidomide when given along with rituximab can help to control the disease and also increase the length...
Phase 3
Toronto, Ontario, Canada and 34 other locations
treatment of advanced classical Hodgkin lymphoma(HL)...
Phase 3
Toronto, Ontario, Canada and 215 other locations
purpose of this study is to assess the objective response rate of parsaclisib treatment in participants with relapsed or refractory follicular lymphoma...
Phase 2
Toronto, Ontario, Canada and 82 other locations
in adult participants with Relapsed or Refractory Non-Hodgkin's Lymphoma (R/R NHL).The study will be conducted in 2 parts: Part A, monothera...
Phase 1
Toronto, Ontario, Canada and 12 other locations
This is a global Phase 2, open-label, single-arm, multicohort, multicenter study to evaluate efficacy and safety of JCAR017 in adult subjects with r/...
Phase 2
Toronto, Ontario, Canada and 37 other locations
Clinical trials
Research sites
Resources
Legal